SCHEMBL25518002

SCHEMBL25518002

CC(C)N[C@@H]1CCCC[C@H]1F

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.36
PIM1 P11309 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13303583 0.81 PIM1 (0.42) KDM4EPIM1
SCHEMBL4417021 0.81 PIM1 (0.42) KDM4EPIM1
SCHEMBL20061124 0.81 PIM1 (0.42) KDM4EPIM1
SCHEMBL21117982 0.81 KDM4E (0.43) KDM4E
SCHEMBL22647693 0.78 PIM1 (0.41) KDM4EPIM1
SCHEMBL17776598 0.78 ADRB2 (0.33) PIM1
SCHEMBL17776589 0.78 ADRB2 (0.33) PIM1
SCHEMBL17776606 0.78 ADRB2 (0.33) PIM1
SCHEMBL21576145 0.76
SCHEMBL21576643 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167133-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF VICKERS VENTURE FUND VI PTE. LTD. (SG) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167133-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF DYRK1A, DYRK1B, DYRK2 KDM4E 1835/4885PIM1 2923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.